Literature DB >> 14642453

Increased auditory startle response and reduced prepulse inhibition of startle in transgenic mice expressing a double mutant form of amyloid precursor protein.

Martha F McCool1, Geoffrey B Varty, Robert A Del Vecchio, Tatiana M Kazdoba, Eric M Parker, John C Hunter, Lynn A Hyde.   

Abstract

Prepulse inhibition (PPI), a form of sensorimotor gating, occurs when an auditory startle response is markedly inhibited by a preceding sub-threshold stimulus (prepulse). Deficits in PPI have been demonstrated in patients with certain psychiatric disorders, such as schizophrenia, and in laboratory animals following specific pharmacological manipulations. Patients with Alzheimer's disease (AD) have not been tested in PPI, but have been shown to have abnormal sensory gating in another paradigm. Transgenic (Tg) CRND8 mice, which model Alzheimer's disease, carry the Swedish and Indiana familial Alzheimer's disease mutations of the human amyloid precursor protein gene and show age-related increases in beta-amyloid (Abeta) production, as well as plaque deposition. The present experiment investigated auditory startle threshold and PPI in TgCRND8 mice at various ages. In two longitudinal studies, PPI was examined in male TgCRND8 mice and non-transgenic (non-Tg) controls at 6-8 weeks of age (pre-plaque), and every 2 weeks thereafter until all mice were at least 16 weeks old (post-plaque). In a cross-sectional study, three different age sets of nai;ve TgCRND8 and non-Tg mice were tested: 10-12, 12-14, and 15-17 weeks old. In all three studies, TgCRND8 mice consistently and robustly demonstrated an enhanced response to a range of auditory startle stimuli compared to non-Tg mice. In addition, the TgCRND8 mice exhibited modest reductions in PPI, compared to non-Tg controls. These PPI deficits were present at pre- and post-plaque time points and did not appear to intensify with age; thus, they do not seem to correlate with the known neuropathology of TgCRND8 mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642453     DOI: 10.1016/j.brainres.2003.09.025

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Hearing loss is an early biomarker in APP/PS1 Alzheimer's disease mice.

Authors:  Yang Liu; Shu Fang; Li-Man Liu; Yan Zhu; Chang-Ri Li; Kaitian Chen; Hong-Bo Zhao
Journal:  Neurosci Lett       Date:  2019-12-20       Impact factor: 3.046

2.  A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.

Authors:  Robert A Maue; Robert W Burgess; Bing Wang; Christine M Wooley; Kevin L Seburn; Marie T Vanier; Maximillian A Rogers; Catherine C Chang; Ta-Yuan Chang; Brent T Harris; David J Graber; Carlos A A Penatti; Donna M Porter; Benjamin S Szwergold; Leslie P Henderson; John W Totenhagen; Theodore P Trouard; Ivan A Borbon; Robert P Erickson
Journal:  Hum Mol Genet       Date:  2011-11-02       Impact factor: 6.150

Review 3.  APP transgenic mice: their use and limitations.

Authors:  Claudia Balducci; Gianluigi Forloni
Journal:  Neuromolecular Med       Date:  2010-12-09       Impact factor: 3.843

Review 4.  Animal Models of Psychosis in Alzheimer Disease.

Authors:  Josh M Krivinko; Jeremy Koppel; Alena Savonenko; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-05-17       Impact factor: 4.105

5.  Neurodegeneration Within the Amygdala Is Differentially Induced by Opioid and HIV-1 Tat Exposure.

Authors:  Sara R Nass; Michael Ohene-Nyako; Yun K Hahn; Pamela E Knapp; Kurt F Hauser
Journal:  Front Neurosci       Date:  2022-05-04       Impact factor: 5.152

Review 6.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

7.  Kalirin reduction rescues psychosis-associated behavioral deficits in APPswe/PSEN1dE9 transgenic mice.

Authors:  Josh M Krivinko; Susan L Erickson; Eric E Abrahamson; Zachary P Wills; Milos D Ikonomovic; Peter Penzes; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2017-02-16       Impact factor: 4.673

8.  Modeling Alzheimer's disease: from past to future.

Authors:  Claudia Saraceno; Stefano Musardo; Elena Marcello; Silvia Pelucchi; Monica Di Luca
Journal:  Front Pharmacol       Date:  2013-06-19       Impact factor: 5.810

Review 9.  Alzheimer disease models and human neuropathology: similarities and differences.

Authors:  Charles Duyckaerts; Marie-Claude Potier; Benoît Delatour
Journal:  Acta Neuropathol       Date:  2007-11-16       Impact factor: 17.088

10.  Big Data Analysis of Genes Associated With Neuropsychiatric Disorders in an Alzheimer's Disease Animal Model.

Authors:  Suji Ham; Tae K Kim; Heeok Hong; Yong S Kim; Ya-Ping Tang; Heh-In Im
Journal:  Front Neurosci       Date:  2018-06-15       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.